PH25365A - Rhase l inhibitor as a marker for virus infections - Google Patents
Rhase l inhibitor as a marker for virus infectionsInfo
- Publication number
- PH25365A PH25365A PH36551A PH36551A PH25365A PH 25365 A PH25365 A PH 25365A PH 36551 A PH36551 A PH 36551A PH 36551 A PH36551 A PH 36551A PH 25365 A PH25365 A PH 25365A
- Authority
- PH
- Philippines
- Prior art keywords
- rhase
- marker
- inhibitor
- virus infections
- infections
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- AIDS & HIV (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13697887A | 1987-12-23 | 1987-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH25365A true PH25365A (en) | 1991-05-13 |
Family
ID=22475294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH36551A PH25365A (en) | 1987-12-23 | 1988-02-24 | Rhase l inhibitor as a marker for virus infections |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0325018A3 (fr) |
| JP (1) | JP2690493B2 (fr) |
| KR (1) | KR890010562A (fr) |
| CN (1) | CN1043569A (fr) |
| AU (2) | AU1256488A (fr) |
| CA (1) | CA1337277C (fr) |
| DK (1) | DK112988A (fr) |
| FI (1) | FI880960L (fr) |
| HU (1) | HU205460B (fr) |
| IL (1) | IL85577A0 (fr) |
| NO (1) | NO880935L (fr) |
| OA (1) | OA08815A (fr) |
| PH (1) | PH25365A (fr) |
| PT (1) | PT86880B (fr) |
| RU (1) | RU1836101C (fr) |
| SU (1) | SU1687035A3 (fr) |
| ZA (1) | ZA881470B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5278042A (en) * | 1989-02-06 | 1994-01-11 | The United States Of America As Represented By The Department Of Health & Human Services | Method for detecting inhibitors of tat protein |
| FR2725214A1 (fr) * | 1994-09-30 | 1996-04-05 | Inst Nat Sante Rech Med | Nouveaux composes utilisables pour la preparation d'agents anti-infectieux |
| US5985565A (en) | 1996-10-09 | 1999-11-16 | Temple University-Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| KR20010042069A (ko) | 1998-03-20 | 2001-05-25 | 베니텍 오스트레일리아 리미티드 | 유전자 발현 조절방법 |
| AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| EP2314700A1 (fr) | 1999-01-28 | 2011-04-27 | Medical College of Georgia Research Institute, Inc | Composition et méthode destinées à l'attenuation in vivo et in vitro de l'expression génique utilisant de l'ARN double brin |
| US6207366B1 (en) | 1999-04-14 | 2001-03-27 | Temple University- Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
| US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
| US20020132257A1 (en) | 2001-01-31 | 2002-09-19 | Tony Giordano | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
| CN112088903A (zh) * | 2020-09-28 | 2020-12-18 | 武汉愔紫生物科技有限公司 | 一种大分子蛋白在抗菌抗病毒消毒剂中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2505845A1 (fr) * | 1981-05-13 | 1982-11-19 | Choay Sa | Procede de dosage de la 2',5'-oligo-adenylate-synthetase, methodes de detection d'une infection virale ou microbienne, de dosage de la concentration de l'interferon circulant ou present dans des tissus, apres administration de l'interferon, ou apres administration d'inducteurs de l'interferon et ensemble pret a l'emploi, ou kit, pour la mise en oeuvre desdits procedes de dosage et methodes de detection et de dosage |
| DE3380200D1 (en) * | 1982-09-16 | 1989-08-24 | William Alvin Carter | Anti-proliferative action of dsnras on tumor cells |
| CA1326450C (fr) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation des manifestations associees au virus du sida au moyen d'arn a double brin |
-
1988
- 1988-02-24 PH PH36551A patent/PH25365A/en unknown
- 1988-02-29 CA CA000560051A patent/CA1337277C/fr not_active Expired - Fee Related
- 1988-02-29 IL IL85577A patent/IL85577A0/xx not_active IP Right Cessation
- 1988-03-02 PT PT86880A patent/PT86880B/pt not_active IP Right Cessation
- 1988-03-02 DK DK112988A patent/DK112988A/da not_active Application Discontinuation
- 1988-03-02 HU HU881015A patent/HU205460B/hu not_active IP Right Cessation
- 1988-03-02 JP JP63047657A patent/JP2690493B2/ja not_active Expired - Fee Related
- 1988-03-02 EP EP88301820A patent/EP0325018A3/fr not_active Withdrawn
- 1988-03-02 FI FI880960A patent/FI880960L/fi not_active Application Discontinuation
- 1988-03-02 AU AU12564/88A patent/AU1256488A/en not_active Abandoned
- 1988-03-02 ZA ZA881470A patent/ZA881470B/xx unknown
- 1988-03-02 NO NO88880935A patent/NO880935L/no unknown
- 1988-03-03 SU SU884355467A patent/SU1687035A3/ru active
- 1988-03-03 OA OA59295A patent/OA08815A/xx unknown
- 1988-03-03 KR KR1019880002189A patent/KR890010562A/ko not_active Ceased
- 1988-03-03 CN CN88101696A patent/CN1043569A/zh active Pending
- 1988-10-26 RU SU884356721A patent/RU1836101C/ru active
-
1992
- 1992-05-12 AU AU16187/92A patent/AU660973B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DK112988A (da) | 1989-06-24 |
| NO880935L (no) | 1989-06-26 |
| EP0325018A3 (fr) | 1990-01-17 |
| ZA881470B (en) | 1988-11-18 |
| CN1043569A (zh) | 1990-07-04 |
| KR890010562A (ko) | 1989-08-09 |
| AU660973B2 (en) | 1995-07-13 |
| DK112988D0 (da) | 1988-03-02 |
| HU205460B (en) | 1992-04-28 |
| FI880960A0 (fi) | 1988-03-02 |
| AU1618792A (en) | 1992-09-10 |
| EP0325018A2 (fr) | 1989-07-26 |
| NO880935D0 (no) | 1988-03-02 |
| JPH01171500A (ja) | 1989-07-06 |
| AU1256488A (en) | 1989-06-29 |
| CA1337277C (fr) | 1995-10-10 |
| JP2690493B2 (ja) | 1997-12-10 |
| PT86880B (pt) | 1993-01-29 |
| OA08815A (en) | 1989-03-31 |
| HUT47745A (en) | 1989-03-28 |
| PT86880A (pt) | 1988-04-01 |
| FI880960A7 (fi) | 1989-06-24 |
| SU1687035A3 (ru) | 1991-10-23 |
| IL85577A0 (en) | 1988-08-31 |
| FI880960L (fi) | 1989-06-24 |
| RU1836101C (ru) | 1993-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0295125A3 (en) | Polyarylamine compounds | |
| EP0295113A3 (en) | Polyarylamine compounds | |
| KR890700853A (ko) | 표 식 | |
| JPS6429365A (en) | Dopamine-beta-hydroxylase inhibitor | |
| PH25365A (en) | Rhase l inhibitor as a marker for virus infections | |
| EP0420804A3 (en) | Anthelmintic compounds | |
| GB9022540D0 (en) | Compound | |
| HK47793A (en) | A flux for cement | |
| GB8824636D0 (en) | Tie marker | |
| GB9016290D0 (en) | Improved magazine for clay targets | |
| GB2217643B (en) | Line marker | |
| IE880586L (en) | RNase L INHIBITOR AS MARKER FOR AIDS | |
| GB8723932D0 (en) | Marker light | |
| GB8911654D0 (en) | Compound | |
| GB8917416D0 (en) | Masonry marker | |
| CA60475S (en) | Marker | |
| GB8717844D0 (en) | Markers | |
| CS862387A1 (en) | Smesny inhibitor koroze oceli | |
| CS25787A1 (en) | Inhibitor koroze | |
| ZA891567B (en) | Lane marker | |
| AU101207S (en) | A marker | |
| IL83693A0 (en) | Assay for virus infections | |
| ZA886709B (en) | Marker devices | |
| GB8909878D0 (en) | Inhibitor | |
| AU104259S (en) | Marker case |